Biomedical engineers at Duke University have demonstrated a new synthetic approach that turbocharges bacteria into producing more of a specific protein, even proteins that would normally destroy them, ...

Former Nimbus Therapeutics CEO brings proven expertise scaling platform biotech companies and executing key strategic partnerships as Strand advances its clinical pipelineBOSTON--(BUSINESS ...

LipidVerse 2025, a landmark one-day conference dedicated to exploring cutting-edge advancements in lipid-based technologies ...

From enzymes and lipid nanoparticles to large-scale process design, four global innovators redefine RNA-based medicine development and delivery.

Plasmid Purification Market to reach USD 6.6 Bn by 2035 at 12.3% CAGR, Driven by rising gene therapy demand, mRNA vaccines, ...

The mammalian elongation complex has remained a mystery – until researchers discovered how it controls its speed.

A district court judge filed an order Tuesday denying a motion to dismiss a Northwestern lawsuit alleging Moderna infringed ...

A new generation of personalized cancer vaccines is taking shape through the use of neoantigen-based dendritic cell (DC) vaccines.

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the effects of specific genetic variants on cancer cell physiology.

Biotech innovator Enhanced Analgesics has won the HealthTech Award at the 2025 InnovationAus Awards for Excellence, ...

“This means a doctor gains a much clearer picture of the tumour – its molecular profile, morphology, and likely response to treatment,” Čekan explained. “Most current tests analyse only a few markers ...

Creative Biogene is always dedicated to providing researchers with the products and tools they deeply need to advance their research to new frontiers.